SCHEMBL20550479

SCHEMBL20550479

O=C(NC1CC1)N1c2nc(-c3cccc(C(F)(F)F)c3)ncc2N2CC[C@H]1C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ PAK1 Q13153 1/20 0.42
▸ RPS6KB1 P23443 1/20 0.42
▸ GRIN1 Q05586 5/20 0.42
▸ GRIN2B Q13224 5/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ KIT P10721 1/20 0.38
▸ KIF11 P52732 1/20 0.38
▸ IDH2 P48735 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17778371 0.97 ALDH1A1 (0.45) ALDH1A1PAK1RPS6KB1GRIN1GRIN2B
SCHEMBL20550603 0.97 ALDH1A1 (0.47) ALDH1A1PAK1RPS6KB1GRIN1GRIN2B
SCHEMBL17769468 0.95 ALDH1A1 (0.43) ALDH1A1PAK1RPS6KB1GRIN1GRIN2B
SCHEMBL17769507 0.95 ALDH1A1 (0.43) ALDH1A1PAK1RPS6KB1GRIN1GRIN2B
SCHEMBL17769661 0.88 IRAK4 (0.39) ALDH1A1PAK1RPS6KB1GRIN1GRIN2B
SCHEMBL17778466 0.88 DPP4 (0.41) ALDH1A1GRIN1GRIN2BCYP2C9CYP2C19
SCHEMBL17769444 0.88 DPP4 (0.41) ALDH1A1GRIN1GRIN2BCYP2C9CYP2C19
SCHEMBL17778498 0.86 PHGDH (0.41) ALDH1A1RPS6KB1CYP2C9CYP2C19KDM4E
SCHEMBL19689787 0.86 KDM1A (0.43) ALDH1A1PAK1RPS6KB1GRIN1GRIN2B
SCHEMBL17768083 0.83 ALDH1A1 (0.43) ALDH1A1RPS6KB1GRIN1GRIN2BKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180319810-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2018-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180319810-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 ALDH1A1 1067/4885PAK1 3632/4885RPS6KB1 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback